You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

Claims for Patent: 6,410,512

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,410,512

Title:	Inhibitors of proteasomal activity for stimulating hair growth
Abstract:	Compounds that inhibit the activity of NF-.kappa.B or inhibit the activity of the proteasome or both promote hair growth and stimulate the production of hair follicles and are thus useful in stimulating hair growth, including hair density, in subject where this is desirable.
Inventor(s):	Mundy; Gregory R. (San Antonio, TX), Garrett; I. Ross (San Antonio, TX), Rossini; G. (San Antonio, TX)
Assignee:	OsteoScreen, Inc. (San Antonio, TX)
Application Number:	09/361,775
Patent Claims:	1. A method to treat a mammalian subject for a condition benefited by stimulating hair growth which method comprises administering to said mammalian subject in need of such treatment an effective amount of N-carbobenzoyl-Ile-Glu-(OtBu)-Ala-Leu-CHO (PSI). 2. The method of claim 1, wherein said subject is a human. 3. The method of claim 1, wherein said condition to be treated is selected from the group consisting of male pattern baldness, alopecia caused by chemotherapy, hair thinning due to aging, and genetic disorders. 4. The method of claim 1, wherein said subject is a non-human mammal. 5. The method of claim 4, wherein said hair growth provides additional protection from cold temperatures. 6. The method of claim 1, wherein said hair growth is due to thickened hair sheath diameter, increased hair diameter, differentiation of quiescent hair follicles into more mature forms, increased rate of growth in hair length and/or thickness, or the appearance of proliferation of new hair follicles. 7. The method of claim 1, wherein said compound is co-administered with an agent promoting skin tissue growth or infiltration. 8. The method of claim 7, wherein said agent is selected from the group consisting of an epidermal growth factor, a fibroblast growth factor, a platelet-derived growth factor, a transforming growth factor, a parathyroid hormone, a leukemia inhibitory factor, and an insulin-like growth factor.

Details for Patent 6,410,512

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2018-07-10
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.